Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

PIONEER 2nd General Assembly

13 - 14 May 2019
Berlin, Germany

Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private aspects of BD4BO

Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology
Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private aspects of BD4BO ( Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology )
13 May 2019

Prof Anders Bjartell discusses the data sources and access of the PIONEER data models

Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden
Prof Anders Bjartell discusses the data sources and access of the PIONEER data models ( Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden )
13 May 2019

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions

Dr Billy Franks - Astellas Pharma B.V.
Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions ( Dr Billy Franks - Astellas Pharma B.V. )
13 May 2019

Denis Horgan explains the importance of actively engaging policy makers in PIONEER

Denis Horgan - Executive Director, European Alliance for Personalised Medicine
Denis Horgan explains the importance of actively engaging policy makers in PIONEER ( Denis Horgan - Executive Director, European Alliance for Personalised Medicine )
13 May 2019

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project

Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office
Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project ( Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office )
13 May 2019

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER

Louise Fullwood - Legal Director, Pinsent Masons
Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER ( Louise Fullwood - Legal Director, Pinsent Masons )
13 May 2019

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success

Prof Maria Ribal - Chairperson, EAU Guidelines Dissemination Committee
Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success ( Prof Maria Ribal - Chairperson, EAU Guidelines Dissemination Committee )
13 May 2019

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer

Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology & Urology Research (TOUR)
Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer ( Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology & Urology Research (TOUR) )
13 May 2019

PIONEER research associates from both academic and industry discuss their experience of working together

Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas Dimitropoulos, Dr Peter-Paul Willemse
PIONEER research associates from both academic and industry discuss their experience of working together ( Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas Dimitropoulos, Dr Peter-Paul Willemse )
13 May 2019

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data

Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals
Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data ( Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals )
13 May 2019

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes

Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi
Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes ( Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi )
13 May 2019